Inhibition of TROP-2 with anti-TROP-2 antibodies decreases migration of colon and breast cancer cells in vitro [51, 57], while overexpression increases the migration of pancreatic cancer cells [31]. This evidence concerns the gene TACSTD2 and familial pancreatic carcinoma.